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Figure S1: Gating around single cells using forward scatter area (FSC-A) and forward scatter height (FSC-H). 
Population 1 (P1), population 2 (P2) and population 3 (P3) were then gated using only single cells. 
 
 
Figure S2: Relative quantitation (RQ) of the expression of the epithelial marker EPCAM, the immune cell marker 
PTPRC and the genes coding for granzyme A (GZMA), granzyme B (GZMB), granzyme H (GZMH), granzyme M 
(GZMM), granulysin (GNLY) and perforin (PRF1) distributed according to the time period post-partum. 




































































































Table S1: Taqman probes from Life Technologies 
Gene Catalogue number 










Table S2: Antibodies used for FACS analysis 
Antibody Dilution Marker style Company Catalogue number 
CD45 – PE-Cy5 1:50 Surface marker BD Biosciences  
CD45 – FITC 1:5 Surface marker BD Biosciences 555482 
EPCAM - FITC 1:10 Surface marker MACS Miltenyi Biotec 347197 
Prf1 – AF647 1:50 Intracellular marker BD Biosciences 563576 
GzmA - PE 1:50 Intracellular marker MACS Miltenyi Biotec 130-099-296 
GzmB – PE  1:10 Intracellular marker BD Biosciences 561142 
GNLY – PE  1:20 Intracellular marker BioLegend 348004 
 
Table S3: Expression of selected genes in human milk cells (HMC)  measured via RT-PCR, normalised to either 
lymphokine activated killer cells (LAK) or resting tissue (RT). Values within this table represent a relative 
quantitation (RQ) compared to these reference samples indicating the fold difference in the expression between 
the sample and the positive control. If the gene expression of the HMC is the same as that of the control, the 
expression will be equal to 1. Values have been rounded to 3 decimal places and where no expression was found, 
this is indicated by ‘-‘. 
Gene Expression in HMC 
Mean (range) 
Expression in HeLa Expression in LAK Expression in RT 
PRF1 0.028 (0.001-0.221) 0.000 0.069 1.095 
PTPRC 0.511 (0.011-8.679) 0.000 1.756 0.711 
GZMA 0.045 (0.000-0.736) - 1.211 0.705 
GZMB 0.105 (0.002-1.594) 0.000 1.777 0.842 
GZMH 0.023 (0.001-0.202) - 0.044 0.801 
GZMM 0.007 (0.001-0.046) 0.003 0.016 0.784 
GNLY 0.080 (0.002-1.240) 0.000 0.130 1.037 







Table S4: Univariate linear mixed modelling of days post-partum and antimicrobial peptide genes, with 
participant as an influencing factor on gene expression 
Response Variable Intercept Slope (days post-partum) SE (slope) P-value (slope) 
GZMA 0.0611 -0.000376 0.000296 0.212 
GZMB 0.169 -0.00132 0.000643 0.047 
GZMH 0.0249 -0.00012 0.0000763 0.122 
GZMM 0.00813 -0.0000383 0.0000261 0.150 
GNLY 0.0857 -0.000496 0.000297 0.102 
PRF1 0.0408 -0.000241 0.000129 0.068 
PTPRC 0.739 -0.00398 0.00335 0.242 
 
Table S5: Flow cytometric analysis of immune and epithelial cell proteins in HM cells (%) taken from healthy, 
mastitis and non-related surgical patient participants. Double stainings between perforin and other immune 
proteins. 
 Healthy (n=12) Mastitis sample (n=1) Post surgery sample 
 Median (Range) Mastitis breast Adjacent breast (n=1) 
Granzyme A – Perforin 





0.0 (0.0 – 0.7) 
0.1 (0.0 – 25.5) 
0.0 (0.0 – 1.1) 











Granzyme B – Perforin 





0.4 (0.0 – 2.8) 
5.7 (3.4 – 23.0) 
0.8 (0.4 – 10.6) 
















Granulysin – Perforin  





0.8 (0.0 – 1.5) 
4.6 (1.7 – 17.6) 
1.6 (0.2 – 2.1) 
0.5 (0.4 – 0.6) 
  
0.3 
3.2 
4.8 
0.1 
 
2.6 
15.5 
19.7 
0.9 
 
 
 
 
 
